Shunji Takahashi

机构：Tohoku University, The Cancer Institute Hospital, Japanese Foundation For Cancer Research · ORCID：0000-0002-5031-1953

发表论文 627 篇 · 总被引 16348 次 · h-index 55

代表论文

• INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2025 · Clinical Cancer Research · 被引 27)
• Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial (2025 · European Journal of Cancer · 被引 27)
• Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial (2025 · Nature Medicine · 被引 21)
• A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma (2025 · Clinical Cancer Research · 被引 18)
• Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study (2025 · The Oncologist · 被引 8)
• Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paraganglioma (2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 被引 7)